-- Surgery 2 Question Bank: Topic 56 - Skin and Soft Tissue Tumours (32 MCQs)
-- Category: Surgery 2 (a0000002-0000-0000-0000-000000000002)
-- Topic: Skin and Soft Tissue Tumours (c0000056-0000-0000-0000-000000000056)

INSERT INTO questions (topic_id, category_id, question_text, option_a, option_b, option_c, option_d, option_e, correct_option, explanation, difficulty, cognitive_level) VALUES
('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The most common skin cancer is:', 'Melanoma', 'Basal cell carcinoma', 'Squamous cell carcinoma', 'Merkel cell carcinoma', 'Kaposi sarcoma', 'B', 'Basal cell carcinoma: most common skin cancer and most common cancer overall. Related to UV exposure. Rarely metastasizes but locally destructive. Fair skin, sun-exposed areas.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Basal cell carcinoma typically presents as:', 'Pigmented lesion', 'Pearly nodule with telangiectasia and rolled edges', 'Rapid growing mass', 'Ulcerated bleeding lesion', 'Scaly patch', 'B', 'BCC presentation: pearly/waxy nodule, telangiectasia, rolled/raised edges. May ulcerate centrally (rodent ulcer). Very slow growing. Common on face (nose, eyelids). Multiple subtypes.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment of basal cell carcinoma includes:', 'Chemotherapy', 'Surgical excision with adequate margins', 'Radiation alone always', 'Immunotherapy', 'Observation', 'B', 'BCC treatment: surgical excision (4mm peripheral margin typically). Mohs surgery for high-risk sites (face). Other options: curettage, cryotherapy (superficial), radiotherapy, topical imiquimod/5-FU (superficial).', 'easy', 'application'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Squamous cell carcinoma of the skin differs from BCC in that:', 'It never metastasizes', 'It has higher metastatic potential', 'It is more common', 'It only occurs on legs', 'It is always pigmented', 'B', 'SCC: second most common skin cancer. Higher metastatic potential than BCC (2-5%). Risk higher with immunosuppression, chronic wounds, scars. Can arise from actinic keratoses.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Risk factors for squamous cell carcinoma of the skin include:', 'Dark skin', 'Chronic UV exposure, immunosuppression, and chronic wounds', 'Obesity', 'Diabetes only', 'Young age', 'B', 'SCC risk factors: chronic UV exposure, fair skin, immunosuppression (transplant patients 65x risk), HPV, chronic wounds/scars (Marjolin ulcer), arsenic, radiation, xeroderma pigmentosum.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Marjolin ulcer is:', 'Primary skin cancer', 'SCC arising in chronic wound, scar, or sinus', 'Benign lesion', 'Melanoma type', 'BCC variant', 'B', 'Marjolin ulcer: SCC arising in chronically damaged skin (burn scar, venous ulcer, osteomyelitis sinus). Aggressive, higher metastatic rate than primary SCC. Often presents late.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Melanoma arises from:', 'Keratinocytes', 'Melanocytes', 'Basal cells', 'Fibroblasts', 'Langerhans cells', 'B', 'Melanoma: malignant tumour of melanocytes. Most dangerous skin cancer due to early metastasis. Risk factors: UV exposure, fair skin, multiple nevi, family history, giant congenital nevus.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The ABCDE criteria for suspicious pigmented lesions are:', 'Size only matters', 'Asymmetry, Border irregularity, Colour variation, Diameter >6mm, Evolution', 'Only color matters', 'Only diameter matters', 'Age, Brown, Central, Dark, Elevated', 'B', 'ABCDE: Asymmetry, Border irregularity, Colour variation, Diameter >6mm, Evolution (change). Helps identify lesions requiring excision/biopsy. Any change in mole should raise concern.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Breslow thickness in melanoma measures:', 'Horizontal spread', 'Vertical depth of invasion from granular layer to deepest tumour cell', 'Lymph node involvement', 'Ulceration size', 'Number of mitoses', 'B', 'Breslow thickness: most important prognostic factor. Measured from granular layer (or ulcer base) to deepest melanoma cell. Determines excision margins, need for SLNB. <1mm = excellent prognosis.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Surgical margins for melanoma are determined by:', 'Location only', 'Breslow thickness', 'Patients age', 'Colour of lesion', 'Size on surface', 'B', 'Melanoma margins: <1mm Breslow = 1cm margin, 1-2mm = 1-2cm margin, >2mm = 2cm margin. Initial excision/biopsy, then wide local excision based on histology. SLNB if Breslow >1mm or other high-risk features.', 'medium', 'application'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Sentinel lymph node biopsy in melanoma is indicated for Breslow thickness:', 'Any thickness', '>1mm or >0.75mm with high-risk features', '<0.5mm', 'Only with palpable nodes', 'Never indicated', 'B', 'SLNB in melanoma: Breslow >1mm, or 0.76-1mm with ulceration/high mitotic rate. Provides staging information, prognostic. If positive, completion lymphadenectomy or surveillance/adjuvant therapy.', 'medium', 'application'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Acral lentiginous melanoma occurs on:', 'Sun-exposed areas', 'Palms, soles, and nail beds', 'Trunk', 'Back only', 'Face only', 'B', 'Acral lentiginous melanoma: palms, soles, subungual (nail bed). Most common melanoma in dark-skinned populations. Not related to sun exposure. Often presents late (not typical sun-exposed sites).', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The most common subtype of melanoma in fair-skinned populations is:', 'Nodular melanoma', 'Superficial spreading melanoma', 'Lentigo maligna melanoma', 'Acral lentiginous', 'Desmoplastic melanoma', 'B', 'Superficial spreading melanoma: most common type (70%). Horizontal growth phase initially (radial), then vertical invasion. Usually on trunk (men), legs (women). Associated with intermittent sun exposure.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Nodular melanoma is the most aggressive because:', 'It is largest', 'It has early vertical growth phase without radial phase', 'It is always ulcerated', 'It occurs on face', 'It is always pigmented', 'B', 'Nodular melanoma: enters vertical growth phase early, lacks horizontal/radial phase. Presents as raised nodule, may be amelanotic. Second most common type but disproportionate mortality.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment advances in metastatic melanoma include:', 'Only chemotherapy', 'Immunotherapy (checkpoint inhibitors) and targeted therapy (BRAF inhibitors)', 'Surgery only', 'Radiation only', 'No effective treatment', 'B', 'Metastatic melanoma treatment: immunotherapy (ipilimumab, pembrolizumab, nivolumab) and targeted therapy (vemurafenib, dabrafenib for BRAF mutated). Revolutionized outcomes. BRAF mutation testing important.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Lipoma is characterized by:', 'Rapid growth', 'Soft, mobile subcutaneous mass that is non-tender', 'Fixed mass', 'Skin changes', 'Rapid enlargement', 'B', 'Lipoma: benign adipose tumour. Soft, mobile, well-circumscribed, non-tender. Most common soft tissue tumour. Single or multiple (lipomatosis). Excision if symptomatic or cosmetic concern.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Features suggesting liposarcoma rather than lipoma include:', 'Small size', 'Size >5cm, deep location, rapid growth, and pain', 'Superficial location', 'Multiple lesions', 'Soft consistency', 'B', 'Liposarcoma concerns: size >5cm, deep/subfascial location, rapid growth, pain, fixation. MRI to assess. Core biopsy for deep/large lesions before excision. Liposarcoma is most common soft tissue sarcoma in adults.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Soft tissue sarcomas most commonly arise in:', 'Skin', 'Extremities (especially lower limb)', 'Head and neck', 'Chest wall', 'Abdomen', 'B', 'Soft tissue sarcomas: extremities most common (60%), especially lower limb. Also retroperitoneum, trunk. Over 50 histological subtypes. Derived from mesenchymal tissue.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The investigation of choice for suspected soft tissue sarcoma is:', 'X-ray', 'MRI', 'Ultrasound', 'CT only', 'Bone scan', 'B', 'MRI: investigation of choice for soft tissue sarcoma. Excellent soft tissue contrast, shows tumour extent, relationship to neurovascular structures. CT for pulmonary staging. Core biopsy for histology.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Treatment of soft tissue sarcoma involves:', 'Chemotherapy alone', 'Wide surgical resection with or without radiotherapy', 'Observation', 'Targeted therapy only', 'Biopsy only', 'B', 'Sarcoma treatment: wide surgical excision (limb-sparing when possible, minimum 1-2cm margin). Radiotherapy (neo/adjuvant) improves local control. Chemotherapy role limited (doxorubicin, ifosfamide). MDT essential.', 'medium', 'application'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Gastrointestinal stromal tumour (GIST) is derived from:', 'Smooth muscle', 'Interstitial cells of Cajal', 'Epithelium', 'Lymphoid tissue', 'Nerve cells', 'B', 'GIST: most common mesenchymal tumour of GI tract. Derived from interstitial cells of Cajal (GI pacemaker cells). Most have KIT (CD117) or PDGFRA mutations. Stomach most common site.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'The targeted therapy for GIST is:', 'Tamoxifen', 'Imatinib (KIT/PDGFRA inhibitor)', 'Trastuzumab', 'Rituximab', 'Bevacizumab', 'B', 'Imatinib: tyrosine kinase inhibitor targeting KIT/PDGFRA. Revolutionized GIST treatment. Used for metastatic/unresectable GIST and adjuvant for high-risk resected GIST. Response rate >80%.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Dermatofibrosarcoma protuberans (DFSP) is characterized by:', 'Rapid metastasis', 'Local recurrence tendency with rare metastasis', 'High mortality', 'Bone involvement', 'Lymph node spread', 'B', 'DFSP: low-grade sarcoma of dermis. High local recurrence (without wide margins) but rarely metastasizes. Typically trunk/proximal limbs. Slow-growing nodular lesion. Mohs or wide excision (2-3cm margins).', 'hard', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Sebaceous cyst (epidermoid cyst) differs from dermoid cyst in that:', 'Dermoid is superficial', 'Epidermoid arises from follicular epithelium, dermoid from sequestered epithelium', 'They are identical', 'Epidermoid is congenital', 'Dermoid is acquired', 'B', 'Epidermoid cyst: arises from follicular epithelium, contains keratin. Dermoid cyst: congenital, contains dermal elements (hair, sebaceous glands), typically at embryonic fusion lines (lateral eyebrow).', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Pilomatrixoma (calcifying epithelioma of Malherbe) typically occurs in:', 'Elderly', 'Children and young adults', 'Neonates', 'Only adults', 'Equal all ages', 'B', 'Pilomatrixoma: benign tumour from hair follicle matrix cells. Children and young adults. Head/neck/upper limbs. Firm, calcified nodule (rock hard). Tent sign (angulated surface). Excision curative.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Keratoacanthoma is:', 'A type of melanoma', 'A rapidly growing tumour that may regress spontaneously, resembling SCC', 'A benign lesion always', 'Never excised', 'Malignant always', 'B', 'Keratoacanthoma: rapidly growing dome-shaped nodule with central keratin plug. May regress spontaneously. Histologically resembles well-differentiated SCC. Often excised due to uncertainty about diagnosis.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Actinic keratosis is a precursor lesion for:', 'BCC', 'SCC', 'Melanoma', 'Merkel cell carcinoma', 'Sarcoma', 'B', 'Actinic keratosis: sun-induced dysplasia. Pre-malignant for SCC (10% progress). Rough, scaly patches on sun-exposed areas. Treatment: cryotherapy, topical 5-FU/imiquimod, photodynamic therapy.', 'easy', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Bowen disease is:', 'Invasive SCC', 'Squamous cell carcinoma in situ', 'BCC variant', 'Melanoma precursor', 'Benign lesion', 'B', 'Bowen disease: SCC in situ. Well-defined erythematous scaly plaque. Full thickness epidermal atypia, intact basement membrane. 3-5% progress to invasive SCC. Treatment: excision, cryotherapy, topical agents.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Merkel cell carcinoma is:', 'A benign lesion', 'A rare, aggressive neuroendocrine carcinoma of the skin', 'A common skin cancer', 'Related to melanocytes', 'Never metastasizes', 'B', 'Merkel cell carcinoma: rare, aggressive neuroendocrine skin cancer. Elderly, immunosuppressed. Associated with Merkel cell polyomavirus. High recurrence and metastasis rates. Treatment: wide excision, SLNB, radiotherapy.', 'hard', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Kaposi sarcoma is associated with:', 'HPV infection', 'Human herpesvirus 8 (HHV-8) and immunosuppression', 'Sun exposure', 'Trauma', 'Genetic syndromes', 'B', 'Kaposi sarcoma: vascular tumour associated with HHV-8 (KSHV). AIDS-defining illness (epidemic KS), also classic (elderly Mediterranean), endemic (African), and iatrogenic (transplant) forms.', 'medium', 'knowledge'),

('c0000056-0000-0000-0000-000000000056'::uuid, 'a0000002-0000-0000-0000-000000000002'::uuid, 'Pyogenic granuloma is:', 'True granuloma with pus', 'A benign vascular proliferation often following trauma', 'Malignant tumour', 'Infectious lesion', 'Pre-malignant', 'B', 'Pyogenic granuloma: misnomer - neither pyogenic nor granulomatous. Lobular capillary hemangioma. Rapidly growing, bleeds easily. Often follows trauma. Pregnancy (granuloma gravidarum). Curettage and cautery.', 'medium', 'knowledge');
